Heath A. Smith

1.2k total citations
16 papers, 866 citations indexed

About

Heath A. Smith is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Heath A. Smith has authored 16 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Heath A. Smith's work include Immunotherapy and Immune Responses (8 papers), vaccines and immunoinformatics approaches (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Heath A. Smith is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), vaccines and immunoinformatics approaches (5 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Heath A. Smith collaborates with scholars based in United States and China. Heath A. Smith's co-authors include Yibin Kang, Douglas G. McNeel, Joshua M. Lang, Brian T. Rekoske, Yong Wei, Brett Maricque, Rumela Chakrabarti, Brian M. Olson, Jens C. Eickhoff and Mary Jane Staab and has published in prestigious journals such as Nature Cell Biology, Cancer Cell and Cancer Research.

In The Last Decade

Heath A. Smith

15 papers receiving 859 citations

Peers

Heath A. Smith

ONCOL

IMMUN

PRM

Kelly N. Fitzgerald United States

Hallvard Haugen Norway

Katsuharu Saito Japan

Christine Gjerdrum Norway

Lizhou Jia China

Guangcun Cheng China

Jillian Phallen United States

W Zhang United States

Linda N. Liu United States

Kelly N. Fitzgerald United States

Heath A. Smith

650 ×1.3

ONCOL

542 ×1.3

IMMUN

433 ×1.2

174 ×1.1

184 ×1.3

PRM

Citations per year, relative to Heath A. Smith Heath A. Smith (= 1×) peers Kelly N. Fitzgerald

Countries citing papers authored by Heath A. Smith

Since Specialization

Citations

This map shows the geographic impact of Heath A. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heath A. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heath A. Smith more than expected).

Fields of papers citing papers by Heath A. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heath A. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heath A. Smith. The network helps show where Heath A. Smith may publish in the future.

Co-authorship network of co-authors of Heath A. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Heath A. Smith. A scholar is included among the top collaborators of Heath A. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heath A. Smith. Heath A. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Guo, Linlin, Weiguo Feng, Ryan Duggan, et al.. (2025). Abstract 6025: ABBV-514: an afucosylated CCR8 specific antibody that targets and eliminates key immunosuppressive tumor regulatory T cells. Cancer Research. 85(8_Supplement_1). 6025–6025.

Shen, Minhong, Heath A. Smith, Yong Wei, et al.. (2021). Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer. Nature Cancer. 3(1). 60–74. 45 indexed citations

Celià-Terrassa, Toni, Daniel Dan Liu, Abrar Choudhury, et al.. (2017). Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a–LCOR axis. Nature Cell Biology. 19(6). 711–723. 77 indexed citations

Smith, Heath A. & Yibin Kang. (2016). Determinants of Organotropic Metastasis. 1(1). 403–423. 31 indexed citations

Rekoske, Brian T., Heath A. Smith, Brian M. Olson, Brett Maricque, & Douglas G. McNeel. (2015). PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope–Modified DNA Vaccine Immunization. Cancer Immunology Research. 3(8). 946–955. 59 indexed citations

Wan, Liling, Xin Lü, Salina Yuan, et al.. (2014). MTDH-SND1 Interaction Is Crucial for Expansion and Activity of Tumor-Initiating Cells in Diverse Oncogene- and Carcinogen-Induced Mammary Tumors. Cancer Cell. 26(1). 92–105. 109 indexed citations

Smith, Heath A., Brian T. Rekoske, & Douglas G. McNeel. (2014). DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses. Vaccine. 32(15). 1707–1715. 14 indexed citations

Smith, Heath A. & Yibin Kang. (2013). The metastasis-promoting roles of tumor-associated immune cells. Journal of Molecular Medicine. 91(4). 411–429. 286 indexed citations

Rekoske, Brian T., Heath A. Smith, & Douglas G. McNeel. (2013). Epitope optimization of a DNA vaccine targeting SSX-2 leads to PD-1 upregulation on antigen-specific CD8 T cells and PD-L1 upregulation on tumor cells. Journal for ImmunoTherapy of Cancer. 1(S1). 2 indexed citations

10.

Smith, Heath A., et al.. (2011). Expression and Immunotherapeutic Targeting of the SSX Family of Cancer–Testis Antigens in Prostate Cancer. Cancer Research. 71(21). 6785–6795. 44 indexed citations

11.

McNeel, Douglas G., Heath A. Smith, Jens C. Eickhoff, et al.. (2011). Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancer. Cancer Immunology Immunotherapy. 61(7). 1137–1147. 78 indexed citations

12.

Zabransky, Daniel J., Heath A. Smith, Christopher J. Thoburn, et al.. (2011). Lenalidomide modulates IL‐8 and anti‐prostate antibody levels in men with biochemically recurrent prostate cancer. The Prostate. 72(5). 487–498. 13 indexed citations

13.

Smith, Heath A. & Douglas G. McNeel. (2011). Vaccines Targeting the Cancer-testis Antigen SSX-2 Elicit HLA-A2 Epitope-specific Cytolytic T Cells. Journal of Immunotherapy. 34(8). 569–580. 24 indexed citations

14.

Smith, Heath A., Brett Maricque, John Eberhardt, et al.. (2010). IgG Responses to Tissue‐Associated Antigens as Biomarkers of Immunological Treatment Efficacy. BioMed Research International. 2011(1). 454861–454861. 12 indexed citations

15.

Smith, Heath A. & Douglas G. McNeel. (2010). The SSX Family of Cancer‐Testis Antigens as Target Proteins for Tumor Therapy. Journal of Immunology Research. 2010(1). 150591–150591. 69 indexed citations

16.

Buckner, Brent, Kayleigh A. Swaggart, Heath A. Smith, et al.. (2008). Expression and Nucleotide Diversity of the Maize RIK Gene. Journal of Heredity. 99(4). 407–416. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact